RESULTS

Structures for Allosteric ligand bound at the TMD of all three TAS1Rs
As described in the METHODS section, the DarwinDock procedure (1) involves sampling ~50,000 poses for each of ~10 diverse ligand conformations from which, we select finally two energetically favorable binding poses based on two scoring methods:
 UCav E: unified cavity energy for which we consider that interactions of the best 100 poses with the union of all residues involve in their separate binding sites (providing a uniform comparison)  BE: snap binding energy considering all interactions of ligand with protein
As a first validation of the predicted structures for the 7 helix TMD, we used DarwinDock to predict the binding site for the allosteric ligands to each TAS1R TMD in Table S10 . Here we find,  S819 [1-((1H-pyrrol-2-yl)methyl)-3-(4-isopropoxyphenyl)thiourea] is a sweet compound that interacts with the TAS1R2 TMD. (2) and  Lactisole is a competitive inhibitor of the sweet taste receptor that binds to TAS1R3 TMD. (3, 4) These structures were further relaxed through annealing. To check the stability of the binding site of these allosteric ligands, we inserted the predicted complexes into an explicit lipid (POPC) and water and carried out 10 ns of MD in physiological salt concentration at 310 K. Figure S2 shows the binding site of  S807 at the TMD of TAS1R1,  S819 at the TMD of TAS1R2, and  lactisole at the TMD of TAS1R3.
GEnSeMBLE predictions of the structures for the 7-helix TMD bundles for all three TASRs of family 1
We sampled 13 trillion combinations of rotations and tilts of the 7 transmembrane helices that we expect to include all plausible packings of the 7 helices into a bundle. Then we used the BiHelix mean field analysis of all pair-wise interactions of these 7 helices to estimate the energy for all 13 trillion packings. Based on this mean field estimate we selected the best 2000, built them into 7-helix bundles, and reevaluated the energy considering interactions of all seven helices with each other. Then we selected the most stable 25 for further analysis.
For TAS1R1 we selected the 3 configurations (t1, t7, t8) with an asterisk from Table S7 . During the MD of TAS1R1 (t8), the HB between N735 (5.47) and CO in S807 at the binding site of the TMD is found to be stable ( Figure S2A ). Also the TAS1R1 MD maintains the salt-bridge interactions in TMs 3-6-7 among R652 (3.46), E758 (6.33), and K811 (7.53). For TAS1R2 we selected the 3 configurations (t1, t9, t19) with an asterisk from Table S8 . For TAS1R3 we selected the 3 configurations (t1, t15, t22) with an asterisk from Table S9. The allosteric ligands bind to the TMD of TAS1Rs (S807 at TAS1R1 t8, S819 at TAS1R2 t19, lactisole at TAS1R3 t15), with the interactions stable in the MD studies.
For TAS1R2, Table S8 shows that 22 out of the top 25 TMD in the ensemble of structures for TAS1R2 contained salt-bridges between the conserved R3.46 and E6.33 at the intracellular interface, coupling TM 3-6, as observed in X-ray structures of inactive Class C GPCR. We observed hydrogen bonding (HB) networks involving TMs 2-3, TMs 3-4-5, (Q4.53-N5.47) and TMs 6-7 that we also found for TAS1R1. But we found an additional salt-bridge between K4.53-D5.47 in the upper TMD of TAS1R2.
For TAS1R1, Table S7 shows that 21 to 24 of the top 25 have close TM3-TM6 interactions at the intracellular surface while 3 out of the 25 do not show this interaction. Based on our previous studies we expect that structure #22 lacking the TM 3-6 interactions may correspond to an active conformation. We also observed HB networks involving TMs 2-3, TMs 3-4-5, (Q4.53-N5.47) and TMs 6-7 in TAS1R1.
The interactions within the TMD for TAS1R1 and TAS1R2 are both consistent with them having an un-activated conformation.
For TAS1R3, the conserved R3.46-E6.33 forming salt bridges in TAS1R1 and TAS1R2 are replaced by Q3.46 and R6.33 in TAS1R3, leading only to HBs in Table S9 . Thus we obtain a 3-6 HB not a salt bridge. As a result, there is no strong 3-6 coupling for 20 of the 25 low lying structures. Instead we find a TM 3-4 salt-bridge between E3.49 and R4.40 for 24 of the 25 structures. Thus TAS1R3 is stabilized in what appears as an activated form with few inter-helical couplings. We find that 19 cases have clearly broken TM 3-6 interactions, so that these 19 structures are candidate active conformations. TAS1R3 has the fewest inter-helical constraints among the three TAS1Rs.
The full TAS1R2/TAS1R3 heterodimer sweet taste receptors 1) Building the structure of the full TAS1R2/TAS1R3 heterodimer The key observations are:
 The dimer interface of the OPRK is formed through contacts of TM1, TM2, and helix8 (H8), denoted at TM12H8/TM12H8, leading to ~1,100 Å 2 buried surface area.  Two different interfaces were found for the crystal structure of the OPRM; TM56/TM56 interface with 1492 Å 2 buried surface area and TM12H8/TM12H8 interface with 615 Å 2 buried surface area. This might indicate a structural basis for the existence of higher-order oligomers (5) or it might just be an artifact of the crystallization in the surfactant. OPRM dimer had interactions between TM56/TM56 for each TMD (Fig. S3 center) .  The β1AR receptor also displayed a TM45/TM45 interface with 900 Å 2 buried surface area and a TM12H8/ TM12H8 interface with 1700 Å 2 buried surface area. (6) These interfaces provided reasonable starting dimer interface structures for our activation studies. For the TM12 dimer, the distance between the start of TM1 for the two TMD bundles is ~20 Å, which is too short to connect the VFD2 and VFD3 domain of the VFD dimer. Since the VFDs would need to be rotated 90˚ to interact with each other as shown in Fig. S3 , we consider Model 12 as physiologically unrealistic.
The TM45/TM45 interface has now been seen in several GPCR structures. For Class C GPCRs biophysical measurements shown that this TM45/TM45 interface is associated with the inactive or resting state (R). In contrast the interface coupling TM6/TM6 on both TMD has been associated with the fully active state (A). (7, 8) Based on the models, we constructed a heterodimer (Fig. S3 ).
OPRM dimer with interaction between TM5/6 for each TMD (Fig. S3 center) . We considered this to Model 12, the distance between the start of TM1 for the two TMD bundles is ~20 Å, which is too short to connect the VFD2 and VFD3 domain of the VFD dimer. Since the VFDs would need to be rotated 90˚ to interact with each other as shown in Fig. S3 , we consider Model 12 as physiologically unrealistic.
2) MD of the 45oo predicted structure of the TAS1R2/TAS1R3 heterodimer
We also carried out 10 ns of MD for the Model 45 ooR apo form with TM45/TM45 interface in an explicit lipid bilayer using the same protocol as for the systems described above. We found that the initial structure was stable over the course of the simulation with no change in the TMD or VFD interfacial configuration. The TAS1R2 and TAS1R3 VFDs remained held tightly together by two salt bridge interactions [E118(R2):K111(R3) and D119(R2):R123(R3)] and a strong polar interaction between Q109(R2) and the backbone NH groups of three residues (K119, A120, G121) forming a sharp turn in TAS1R3. The two CRD domains exhibit a hydrophobic interaction [L521(R2):T539+F540(R3)]. The TM domains of TAS1R2 and TAS1R3 showed stable salt bridge interaction R674(R2):E663(R3) across the two ICL2 loops. In addition, The TM4/5 interface was held tightly in place by two groups of hydrophobic interactions:
Fig. S10 shows these interactions, which are the main chemical couplings keeping the sweet receptor inactive. We see that they span the whole receptor from the VFD to the CRD, to the TMD. Many of these interactions would need to be broken during receptor activation as the TMD interface switches from the TM45/TM45 interface to the TM56/TM56 interface while the VFD dimer switches from the ooR to the coA conformation, as suggested by many biophysical observations on mGluR. (7, (9) (10) (11) MD of the TAS1R2/TAS1R3 heterodimer bound with Stev.
To check the stability of the predicted binding site of Stev, we inserted the predicted VFD heterodimer complex into a periodic box with explicit and water at physiological salt concentration (103,993 total atoms) and carried out 12 ns of MD at 310 K. As shown in Fig S7 , the Stev binding site shows overall stability through all 12 ns MD, with some minor changes in the HBs at the binding site of the flexible hydroxyl group of the glucose ring. We find that the strong interactions at D142 and E302, which are critical residues for sucrose activity, were maintained during the MD (Fig. S5A) . We observed new HB interactions from N70 with the OH group (Fig. S5B & Table  S11 ). In addition, we found additional water-mediated interactions: (a) At 3.3 ns one water inserted into the binding cavity and (b) at 5.5 ns another water molecule formed a water mediated HB (Fig.  S5C) . We also observed that the intramolecular HBs in Stev are maintained (Fig. S5D & Fig. S6 ).
To select the best binding pose from the 12 ns MD trajectory, we calculated the interaction energy between protein and ligands along the trajectory and selected the 6 snapshots in Fig. S7 , with good interaction energies. Then we matched 4 known Stev analogues into the binding site to examine if these structures could explain experimental structure-activity relationship (SAR) of various Stev derivatives.(8) All 5 Stev derivatives show the important interactions displayed in orange at all 6 time steps, especially at D142 and E302, with additional interactions depending on the terminal sugar orientations/ conformations. In addition, we find no interactions of these Stev type molecules with the residues in purple that were established from mutational studies to not be important in activation. Fig. S8 displays the pharmacophore map at 6 different time steps.
The short MD simulations of MogV bound complex also support the stability of the MogV binding site. The predicted binding site of MogV with the TAS1R2/ TAS1R3 VFD heterodimer indicates that D278 stabilizes the conformation through interaction with K65. As in the Stev-bound complex, we also observed that the electrostatic interactions between K65 and D278 remain stable through the MD, stabilizing the conformation. We also find that R383 stabilizes the conformation through interaction with D307 at VFD2, favoring the closed conformation.
METHODS
Structure predictions for TAS1Rs
We used the GEnSeMBLE method (12) to generate the 3D structures for the ensemble TMD conformations of all TAS1Rs. GEnSeMBLE evaluates mean field energies for all the conformations sampled by varying the helix tilts and rotations (13 trillion) . This leads to selection of ~25 low energy conformations to be used for binding to different ligands. This structure prediction methodology has been described previously,(12) but we summarize it here:
1.1 Homologize Helices: Since all TAS1Rs belongs to Class C GPCRs with 17.29~25.14% sequence identities in the TMD, we generated the homology helices using the X-ray structures of Class C GPCRs: human mGluR1 (PDB ID: 4OR2)(13) and mGluR5 (PDB ID: 4OO9). (14) We also used these two structures as the starting template for our complete sampling of rotations and tilts.
BiHelix:
We sample all possible helix rotation combinations leading to (12) 7 ~ 35 million packings. Starting with the two templates, we find that the lowest energy conformations from BiHelix do not show rotation angle changes from the X-ray structure of the templates.
SuperBiHelix:
In this step, helix tilt angles are added to helix rotations for rigorous conformational sampling in the membrane. (15) This leads to a sampling of ~13 trillion conformations. The top 25 structures by energy were selected for further use and analysis.
Loop generation:
After optimizing the TM domains, we constructed the loops using homology to human mGluR1 (PDB ID: 4OR2)(13) for hTAS1R1/ 3 and human mGluR5 (PDB ID: 4OO9) (14) for hTAS1R2. The loops and the N/C terminus including helix 8 for each new structure were modeled through homology with the template structure, and then relaxed through 10 cycles of simulated annealing with fixed TM domains between 50 K and 600 K each for 100 ps per cycle. We then minimized the whole structures up to 1000 CG steps but terminating when the RMS forces are below 0.5 kcal/mol-A. The disulfide bridges between C630
3.25 and C720 in TAS1R2, and between C633
3.25 and C722 in TAS1R3 (conserved among most GPCRs) were constructed by homology. The lowest energy loops were used to generate the full structure of the TMD.
VFD and CRD generation:
X-ray structures of the VFD in Class C GPCRs suggest 5 possible dimer conformations. Agonist induced transformations between these structures plays a role in receptor activation of Class C GPCR dimers. We constructed the "oo" resting state based on the rat metabotropic glutamate receptor 1 (mGluR1) structure (PDBid: 1ewt).(16) We based the "co" and "cc" active states apo structures on homology modeling of rat mGluR1 (PDBid: 1ewk)(16) and human mGluR5 (PDBid: 3lmk) respectively. The rat mGluR3 was used as a template for modeling the CRD domain. The homology modeling was performed with the Swiss-Model server(17) using the above mentioned crystal structure templates as input. The disulfide bridges in the N-terminal domain of TAS1R2 were constructed by homology:
C59-C102, C359-C363, C405-C410 in the VFD, C495-C514, C499-C517, C520-C535, C538-C551 in the CRD, and C233-C513 between the VFD and CRD.
The disulfide bridges in the N-terminal domain of TAS1R3 were constructed by homology:
C62-C103, C351-C370, C373-C375, C410-C415 in the VFD, C499-C518, C503-C521, C524-C538, C541-C554 in the CRD, and C236-C517 between the VFD and CRD.
Heterodimer generation:
To construct the heterodimer with TMD interfaces between TAS1R2 and TAS1R3, we used recent crystal structures of Class A µ opioid receptor (OPRM),(5) κ opioid receptor (OPRK), (18) and β1 adrenergic receptor (β1AR). (6) The crystal structures of OPRM (PDB: 4DKL), OPRK (PDB: 4DJH), and β1AR (PDB: 4GPO) were used as a template for the structure alignment to generate a parallel, symmetric dimer with symmetric dimeric interfaces. We aligned each monomer to the template using Protein Structure Alignment tool in the Maestro software. (19) 
Predicting ligand binding sites
For each ligand multiple torsional conformations are used in DarwinDock (1) that iteratively generates ~50,000 poses in the putative binding regions. The amino acid sidechains in the binding site are optimized for each ligand pose, the resulting complex is neutralized, and its energy minimized as described earlier.(26) This procedure was followed for each of ligand conformations generated as follows. Starting from the minimized structure of the S807, S819, lactisole and the Xray structures of sucrose and stevioside ligands, we performed conformational searches of Mixed torsional/ Low-mode sampling (1000 steps, 1000 steps per rotatable bond, 10 kcal/mol of energy window, 0.5 Å of RMSD) using the Maestro software.(19) The low energy conformations were reminimized using the Dreiding force field (20) were inserted into a continuous infinite POPC lipid bilayer membrane with periodic boundary conditions while including full solvation with water at physiological salt concentration. We then carried out 10 ns MD at 300 K. In these calculations H641 (3.33) and H734 (5.44) in TAS1R3 were treated as a protonated His, HSP. The procedure here was identical to that in Kim. et al. (21) 3.2 Stevioside bound to the VFD of TAS1R2/TAS1R3 heterodimer: The predicted structure for stevioside bound to the VFD of TAS1R2/ TAS1R3 heterodimer (104,173 total atoms including 29,778 waters, 101 Na + , 79 Cl -) was inserted into a continuous infinite POPC lipid bilayer membrane with periodic boundary conditions while including full solvation with water in physiological salt concentration. We then carried out 12 ns MD at 300 K.
Stevioside and S819 bound the whole complex of TAS1R2/ TAS1R3 heterodimer:
The DarwinDock predicted structure for stevioside and S819 bound to the whole complex of TAS1R2/ TAS1R3 heterodimer was inserted into a continuous infinite lipid bilayer POPC membrane with periodic boundary conditions while including full solvation with water in physiological salt concentration (177,398 total atoms including 40,030 waters, 117 Na + , 107 Cl -). We then carried out 30 ns MD at 300 K.
The following disulfide bridges in TAS1R2 were constrained: C59-C102, C359-C363, C405-C410 in the VFD, C495-C514, C499-C517, C520-C535, C538-C551 in CRD, C233-C513 between VFD and CRD, and
C630
3.25 -C720 between TMDTMD and EC2.
The disulfide bridges in TAS1R3 were also constrained:
C236-C517 between VFD and CRD, and C633 3.25 and C722 between TMDTMD and EC2.
The POPC lipid available in VMD is used to insert the protein into a lipid-water box, lipids within 1 Å of protein and waters within 2 Å of the protein are removed.
For the particle mesh Ewald (PME) in the electrostatics calculation,(22) the charge of system was balanced through replacing waters into Na + and Cl -ions. Here we used AMBER tool tleap to place the ions at their best electrostatic potions. After inserting the 7 helix bundle including loops into the box containing the periodic POPC membrane, water, and ions, we fixed the protein and minimized the lipid, water, ion atoms for 1,000 steps, and then equilibrated with NPT dynamics for 500 ps while continuing to keep the protein fixed. This allows the lipid and water to readjust to the protein. Then we minimized the full system for 1,000 steps and then performed NPT dynamics. This predicted structure was then equilibrated at 300 K using the NAMD 2.9 (NAnoscale Molecular Dynamics) program. (23) We used the CHARMM22 force field parameters for the protein, the TIP3 model for water, (24) and the CHARMM27 force field parameters for the lipids. (25) Table S7 . The interhelical polar interactions for the top 25 TMD conformations for TAS1R1 from the SuperBiHelix analysis. The tilt (θ, φ) and rotation (η) angles for these 25 are given in Table S4 . We see that all cases have a strong R3.46 to E6.33 salt bridge, except #22 where it is clearly broken, and for #10, #7, and perhaps #13 where it is long. Thus these 1 to 4 structures (shown in grey) might be candidates for active conformation are. The H-bond distances (Å) between pairs of hetero atoms were measured. Table S8 . The interhelical polar interactions for the top 25 TMD conformations for TAS1R2 from the SuperBiHelix analysis. The tilt (θ, φ) and rotation (η) angles for these 25 are given in Table S5 . We see that all cases have a strong R3.46 to E6.33 salt bridge, except #19 and 25 where it is clearly broken, and for #23 where it is long. Thus these 2 to 3 structures (shown in grey) might be candidates for active conformation. Table S13 . The structures of the ligands and the sweetness data for 500 ppm (Grey). All cases started with the same initial conformation of the heterodimer with the 38.7 Å distances for coA. The distances after 10 ns molecular dynamics at 310 K are averaged over the period from 8-10ns. We list the following;
 The average distance (Å) between the geometric center of lower VFD2 and lower VFD3 (Avg lower VFD Dis.) in Fig. 1 . Here we consider that distances more than 1 Å closer than the 43 Å for the apo case indicate activation. 9 of 10 cases are consistent. The outlier is Rubu.
 The average distance (Å) between the closest Cα of TM6 for TMD2 with a Cα of TM6 for TMD3 (Avg TM6-6' Cα Dis.) in Fig. 1 Figure S1 . Sequence alignments of the three human TAS1R sweet receptors (hTAS1R1, hTAS1R2, hTAS1R3) with X-ray templates of human metabotropic glutamate receptor (mGluR), mGluR1 and mGluR5 based on the PredicTM method. Most residues of the Nand C-termini are omitted. The predicted transmembrane (TM) regions from PredicTM are displayed in colored boxes. The X.50 residues from Ballesteros-Weinstein numbering (BW#) and the highly conserved residues in all TAS1Rs are shown in black boxes. Figure S16. Trajectory analysis of total number Cα between the two TM6s within 9 Å after 10ns of MD.
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